Hi, what are you looking for?
Jewish Business News
Search results for "Pluristem "
Business
The German Ministry of Health has approved Israeli Pluristem's drug, from women's placenta cells after cesarean section. Placenta have been shown to induce a...
StartUps
Pluristem, an Israeli biotech startup, has sold a 17% stake in the company to the Chinese firm Innovative Medical. The company’s stock soared 8%...
Business
PLX-PAD cells treatment for severe preeclampsia is among the most common medical complications of pregnancy
StartUps
Alongside the study at Hadassah, a preliminary study was conducted by Hillard M. Lazarus, MD, a Professor of Medicine in the Department of Hematology...
StartUps
PLX-PAD cells show statistically significant improvement over placebo in the change of the maximal contraction force of the gluteal muscle .
Business
Pluristem issues shares to CHA at a price per share of $4.16. The agreement includes Development and Commercialization of PLX-PAD cells for the Treatment...
Business
– – The Israeli stem cell company, Pluristem Therapeutics Ltd. (Nasdaq:PSTI; DAX: PJT: PLTR) has signed a strategic partnership and exclusive licensing agreement with...
Life science
Israel's innovators in the field of diagnostics, treatment, care management are much more, adapting technologies to ease the coronavirus burden on the world.
Bio-Tech
Pluristem and U.S. Department of Defense Studies present a significant increase in Acute Radiation Poisoning survival rates, from 4% in the placebo group to...
VC, Investments
The approved projects involve innovations in the areas of agrotechnology, biotechnology, material sciences, homeland security and more